KLF4 and neoplasm: Specifically, in melanoma, miR‐150‐3p downregulates KLF4 expression, thereby preventing KLF4 from binding to the promoter region of NCK2 and suppressing its transcription, ultimately leading to inhibition of tumor cell growth.